{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:11:47Z","timestamp":1792707107688,"version":"4.5.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr HIV\/AIDS Rep"],"DOI":"10.1007\/s11904-026-00780-5","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T03:37:33Z","timestamp":1774582653000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Implications of HIV-1 Subtypes on Pathogenesis, Reservoirs and Cure Strategies"],"prefix":"10.1007","volume":"23","author":[{"given":"Kavidha","family":"Reddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thumbi","family":"Ndung\u2019u","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"780_CR1","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.20492","author":"F Blanquart","year":"2016","unstructured":"Blanquart F, Grabowski MK, Herbeck J, Nalugoda F, Serwadda D, Eller MA, et al. A transmission-virulence evolutionary trade-off explains attenuation of HIV-1 in Uganda. Elife. 2016. https:\/\/doi.org\/10.7554\/eLife.20492.","journal-title":"Elife"},{"issue":"10","key":"780_CR2","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1089\/aid.2010.0054","volume":"26","author":"SA Conroy","year":"2010","unstructured":"Conroy SA, Laeyendecker O, Redd AD, Collinson-Streng A, Kong X, Makumbi F, et al. Changes in the distribution of HIV type 1 subtypes D and A in Rakai District, Uganda between 1994 and 2002. AIDS Res Hum Retroviruses. 2010;26(10):1087\u201391.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"780_CR3","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328330cc08","author":"N Kiwanuka","year":"2009","unstructured":"Kiwanuka N, Laeyendecker O, Quinn TC, Wawer M, Shepherd J, Robb M, et al. HIV-1 subtypes and differences in heterosexual HIV transmission among HIV-discordant couples in Rakai, Uganda. AIDS. 2009. https:\/\/doi.org\/10.1097\/QAD.0b013e328330cc08.","journal-title":"AIDS"},{"issue":"2","key":"780_CR4","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/QAI.0b013e3181c98fc0","volume":"54","author":"N Kiwanuka","year":"2010","unstructured":"Kiwanuka N, Robb M, Laeyendecker O, Kigozi G, Wabwire-Mangen F, Makumbi FE, et al. HIV-1 viral subtype differences in the rate of CD4\u2009+\u2009T-cell decline among HIV seroincident antiretroviral naive persons in Rakai district, Uganda. J Acquir Immune Defic Syndr. 2010;54(2):180\u20134.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"780_CR5","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.jinf.2012.10.026","volume":"66","author":"J Hemelaar","year":"2013","unstructured":"Hemelaar J. Implications of HIV diversity for the HIV-1 pandemic. J Infect. 2013;66(5):391\u2013400.","journal-title":"J Infect"},{"issue":"2","key":"780_CR6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S1473-3099(18)30647-9","volume":"19","author":"J Hemelaar","year":"2019","unstructured":"Hemelaar J, Elangovan R, Yun J, Dickson-Tetteh L, Fleminger I, Kirtley S, et al. Global and regional molecular epidemiology of HIV-1, 1990\u20132015: a systematic review, global survey, and trend analysis. Lancet Infect Dis. 2019;19(2):143\u201355.","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"780_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(24)00151-4","volume":"5","author":"M Nair","year":"2024","unstructured":"Nair M, Gettins L, Fuller M, Kirtley S, Hemelaar J. Global and regional genetic diversity of HIV-1 in 2010-21: systematic review and analysis of prevalence. Lancet Microbe. 2024;5(11):100912.","journal-title":"Lancet Microbe"},{"key":"780_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/v15020465","author":"HP Kohio","year":"2023","unstructured":"Kohio HP, Ajoge HO, Coleman MD, Ndashimye E, Gibson RM, Arts EJ, et al. Specialized DNA structures act as genomic beacons for integration by evolutionarily diverse retroviruses. Viruses. 2023. https:\/\/doi.org\/10.3390\/v15020465.","journal-title":"Viruses"},{"key":"780_CR9","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1126\/scitranslmed.abd8179","volume":"13","author":"MVP Gondim","year":"2021","unstructured":"Gondim MVP, Sherrill-Mix S, Bibollet-Ruche F, Russell RM, Trimboli S, Smith AG, et al. Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption. Sci Transl Med. 2021;13:576.","journal-title":"Sci Transl Med"},{"issue":"Suppl 1","key":"780_CR10","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1186\/1479-5876-9-S1-S5","volume":"9","author":"H Schuitemaker","year":"2011","unstructured":"Schuitemaker H, van \u2018t Wout AB, Lusso P. Clinical significance of HIV-1 coreceptor usage. J Transl Med. 2011;9(Suppl 1):S5.","journal-title":"J Transl Med"},{"key":"780_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/v11121104","author":"I Sarabia","year":"2019","unstructured":"Sarabia I, Bosque A. HIV-1 latency and latency reversal: does subtype matter? Viruses. 2019. https:\/\/doi.org\/10.3390\/v11121104.","journal-title":"Viruses"},{"key":"780_CR12","volume-title":"Fact sheet 2025: Global HIV statistics","author":"UNAIDS","year":"2025","unstructured":"UNAIDS. Fact sheet 2025: Global HIV statistics. Geneva: Joint United Nations Programme on HIV\/AIDS (UNAIDS); 2025."},{"key":"780_CR13","doi-asserted-by":"publisher","first-page":"103233","DOI":"10.1016\/j.eclinm.2025.103233","volume":"83","author":"JAC Hontelez","year":"2025","unstructured":"Hontelez JAC, Goymann H, Berhane Y, Bhattacharjee P, Bor J, Chabata ST, et al. The impact of the PEPFAR funding freeze on HIV deaths and infections: a mathematical modelling study of seven countries in sub-Saharan Africa. EClinicalMedicine. 2025;83:103233.","journal-title":"EClinicalMedicine"},{"issue":"3","key":"780_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26431","volume":"28","author":"KH Tram","year":"2025","unstructured":"Tram KH, Ratevosian J, Beyrer C. By executive order: the likely deadly consequences associated with a 90-day pause in PEPFAR funding. J Int AIDS Soc. 2025;28(3):e26431.","journal-title":"J Int AIDS Soc"},{"key":"780_CR15","doi-asserted-by":"publisher","DOI":"10.18356\/9789211544350","volume-title":"Global AIDS Update 2025","author":"UNAIDS","year":"2025","unstructured":"UNAIDS. Global AIDS Update 2025. Geneva: Joint United Nations Programme on HIV\/AIDS; 2025."},{"issue":"1","key":"780_CR16","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006841","volume":"1","author":"PM Sharp","year":"2011","unstructured":"Sharp PM, Hahn BH. Origins of HIV and the AIDS pandemic. Cold Spring Harb Perspect Med. 2011;1(1):a006841.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"780_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/bmb\/58.1.19","volume":"58","author":"B Korber","year":"2001","unstructured":"Korber B, Gaschen B, Yusim K, Thakallapally R, Kesmir C, Detours V. Evolutionary and immunological implications of contemporary HIV-1 variation. Br Med Bull. 2001;58:19\u201342.","journal-title":"Br Med Bull"},{"issue":"10","key":"780_CR18","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1097\/QAD.0b013e32835461b5","volume":"26","author":"T Ndung\u2019u","year":"2012","unstructured":"Ndung\u2019u T, Weiss RA. On HIV diversity. AIDS. 2012;26(10):1255\u201360.","journal-title":"AIDS"},{"issue":"1517","key":"780_CR19","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1098\/rstb.2008.0185","volume":"364","author":"MH Malim","year":"2009","unstructured":"Malim MH. APOBEC proteins and intrinsic resistance to HIV-1 infection. Philos Trans R Soc Lond B Biol Sci. 2009;364(1517):675\u201387.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"6353","key":"780_CR20","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/354453a0","volume":"354","author":"RE Phillips","year":"1991","unstructured":"Phillips RE, Rowland-Jones S, Nixon DF, Gotch FM, Edwards JP, Ogunlesi AO, et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature. 1991;354(6353):453\u20139.","journal-title":"Nature"},{"issue":"6929","key":"780_CR21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature01470","volume":"422","author":"X Wei","year":"2003","unstructured":"Wei X, Decker JM, Wang S, Hui H, Kappes JC, Wu X, et al. Antibody neutralization and escape by HIV-1. Nature. 2003;422(6929):307\u201312.","journal-title":"Nature"},{"issue":"11","key":"780_CR22","doi-asserted-by":"publisher","first-page":"e772","DOI":"10.1016\/S2352-3018(20)30252-6","volume":"7","author":"J Hemelaar","year":"2020","unstructured":"Hemelaar J, Elangovan R, Yun J, Dickson-Tetteh L, Kirtley S, Gouws-Williams E, et al. Global and regional epidemiology of HIV-1 recombinants in 1990\u20132015: a systematic review and global survey. Lancet HIV. 2020;7(11):e772\u201381.","journal-title":"Lancet HIV"},{"issue":"11","key":"780_CR23","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1093\/infdis\/jiad327","volume":"228","author":"A Williams","year":"2023","unstructured":"Williams A, Menon S, Crowe M, Agarwal N, Biccler J, Bbosa N, et al. Geographic and Population Distributions of Human Immunodeficiency Virus (HIV)-1 and HIV-2 Circulating Subtypes: A Systematic Literature Review and Meta-analysis (2010\u20132021). J Infect Dis. 2023;228(11):1583\u201391.","journal-title":"J Infect Dis"},{"key":"780_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens9121072","author":"M Giovanetti","year":"2020","unstructured":"Giovanetti M, Ciccozzi M, Parolin C, Borsetti A. Molecular epidemiology of HIV-1 in African countries: a comprehensive overview. Pathogens. 2020. https:\/\/doi.org\/10.3390\/pathogens9121072.","journal-title":"Pathogens"},{"issue":"2","key":"780_CR25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1023\/A:1023435429841","volume":"26","author":"MA Papathanasopoulos","year":"2003","unstructured":"Papathanasopoulos MA, Hunt GM, Tiemessen CT. Evolution and diversity of HIV-1 in Africa\u2013a review. Virus Genes. 2003;26(2):151\u201363.","journal-title":"Virus Genes"},{"key":"780_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1576667","volume":"16","author":"D Nakanjako","year":"2025","unstructured":"Nakanjako D, Kankaka EN, Lungu C, Galiwango RM, Reynolds SJ, Mahmoudi T, et al. Hiv cure research contributions from Africa in the last three decades. Front Immunol. 2025;16:1576667.","journal-title":"Front Immunol"},{"issue":"3","key":"780_CR27","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/COH.0000000000000534","volume":"14","author":"N Bbosa","year":"2019","unstructured":"Bbosa N, Kaleebu P, Ssemwanga D. Hiv subtype diversity worldwide. Curr Opin HIV AIDS. 2019;14(3):153\u201360.","journal-title":"Curr Opin HIV AIDS"},{"issue":"9839","key":"780_CR28","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0140-6736(12)60821-6","volume":"380","author":"C Beyrer","year":"2012","unstructured":"Beyrer C, Baral SD, van Griensven F, Goodreau SM, Chariyalertsak S, Wirtz AL, et al. Global epidemiology of HIV infection in men who have sex with men. Lancet. 2012;380(9839):367\u201377.","journal-title":"Lancet"},{"key":"780_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.00655","volume":"10","author":"E Delgado","year":"2019","unstructured":"Delgado E, Benito S, Montero V, Cuevas MT, Fernandez-Garcia A, Sanchez-Martinez M, et al. Diverse large HIV-1 non-subtype B clusters are spreading among men who have sex with men in Spain. Front Microbiol. 2019;10:655.","journal-title":"Front Microbiol"},{"key":"780_CR30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2174\/1874613601610010034","volume":"10","author":"AB Kharsany","year":"2016","unstructured":"Kharsany AB, Karim QA. Hiv infection and AIDS in sub-Saharan Africa: current status, challenges and opportunities. Open AIDS J. 2016;10:34\u201348.","journal-title":"Open AIDS J"},{"issue":"1","key":"780_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/1742-6405-10-30","volume":"10","author":"G Ramjee","year":"2013","unstructured":"Ramjee G, Daniels B. Women and HIV in Sub-Saharan Africa. AIDS Res Ther. 2013;10(1):30.","journal-title":"AIDS Res Ther"},{"issue":"11","key":"780_CR32","doi-asserted-by":"publisher","first-page":"e298","DOI":"10.1371\/journal.pmed.0020298","volume":"2","author":"B Auvert","year":"2005","unstructured":"Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 trial. PLoS Med. 2005;2(11):e298.","journal-title":"PLoS Med"},{"issue":"9630","key":"780_CR33","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1016\/S0140-6736(08)60896-X","volume":"371","author":"RH Gray","year":"2008","unstructured":"Gray RH, Wawer MJ. Reassessing the hypothesis on STI control for HIV prevention. Lancet. 2008;371(9630):2064\u20135.","journal-title":"Lancet"},{"key":"780_CR34","first-page":"31","volume":"407","author":"DC Monaco","year":"2017","unstructured":"Monaco DC, Ende Z, Hunter E. Virus-host gene interactions define HIV-1 disease progression. Curr Top Microbiol Immunol. 2017;407:31\u201363.","journal-title":"Curr Top Microbiol Immunol"},{"issue":"8","key":"780_CR35","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1086\/512682","volume":"195","author":"JM Baeten","year":"2007","unstructured":"Baeten JM, Chohan B, Lavreys L, Chohan V, McClelland RS, Certain L, et al. HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads. J Infect Dis. 2007;195(8):1177\u201380.","journal-title":"J Infect Dis"},{"issue":"8","key":"780_CR36","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1097\/QAD.0000000000001437","volume":"31","author":"TD Mangal","year":"2017","unstructured":"Mangal TD, Progression UWGoC, Mortality Amongst HIVSitCCiE. Joint estimation of CD4\u2009+\u2009cell progression and survival in untreated individuals with HIV-1 infection. AIDS. 2017;31(8):1073\u201382.","journal-title":"AIDS"},{"issue":"2","key":"780_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031674","volume":"7","author":"M Parczewski","year":"2012","unstructured":"Parczewski M, Leszczyszyn-Pynka M, Bander D, Urbanska A, Boron-Kaczmarska A. HIV-1 subtype D infections among Caucasians from Northwestern Poland\u2013phylogenetic and clinical analysis. PLoS One. 2012;7(2):e31674.","journal-title":"PLoS One"},{"issue":"5","key":"780_CR38","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1093\/infdis\/jit416","volume":"209","author":"AA Palm","year":"2014","unstructured":"Palm AA, Esbj\u00f6rnsson J, M\u00e5nsson F, Kvist A, Isberg P-E, Biague A, et al. Faster Progression to AIDS and AIDS-Related Death Among Seroincident Individuals Infected With Recombinant HIV-1 A3\/CRF02_AG Compared With Sub-subtype A3. J Infect Dis. 2014;209(5):721\u20138.","journal-title":"J Infect Dis"},{"key":"780_CR39","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00253-17","author":"MW Kiguoya","year":"2017","unstructured":"Kiguoya MW, Mann JK, Chopera D, Gounder K, Lee GQ, Hunt PW, et al. Subtype-specific differences in Gag-Protease-driven replication capacity are consistent with intersubtype differences in HIV-1 disease progression. J Virol. 2017. https:\/\/doi.org\/10.1128\/JVI.00253-17.","journal-title":"J Virol"},{"issue":"9","key":"780_CR40","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1086\/340130","volume":"185","author":"P Kaleebu","year":"2002","unstructured":"Kaleebu P, French N, Mahe C, Yirrell D, Watera C, Lyagoba F, et al. Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda. J Infect Dis. 2002;185(9):1244\u201350.","journal-title":"J Infect Dis"},{"key":"780_CR41","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.ebiom.2016.10.014","volume":"13","author":"CM Venner","year":"2016","unstructured":"Venner CM, Nankya I, Kyeyune F, Demers K, Kwok C, Chen PL, et al. Infecting HIV-1 Subtype Predicts Disease Progression in Women of Sub-Saharan Africa. EBioMedicine. 2016;13:305\u201314.","journal-title":"EBioMedicine"},{"key":"780_CR42","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00518-17","author":"VL Naidoo","year":"2017","unstructured":"Naidoo VL, Mann JK, Noble C, Adland E, Carlson JM, Thomas J, et al. Mother-to-child HIV transmission bottleneck selects for consensus virus with lower Gag-Protease-driven replication capacity. J Virol. 2017. https:\/\/doi.org\/10.1128\/JVI.00518-17.","journal-title":"J Virol"},{"issue":"1","key":"780_CR43","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1038\/s41467-020-15632-y","volume":"11","author":"E Adland","year":"2020","unstructured":"Adland E, Millar J, Bengu N, Muenchhoff M, Fillis R, Sprenger K, et al. Sex-specific innate immune selection of HIV-1 in utero is associated with increased female susceptibility to infection. Nat Commun. 2020;11(1):1767.","journal-title":"Nat Commun"},{"issue":"6","key":"780_CR44","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1128\/JVI.01970-08","volume":"83","author":"CL Boutwell","year":"2009","unstructured":"Boutwell CL, Rowley CF, Essex M. Reduced viral replication capacity of human immunodeficiency virus type 1 subtype C caused by cytotoxic-T-lymphocyte escape mutations in HLA-B57 epitopes of capsid protein. J Virol. 2009;83(6):2460\u20138.","journal-title":"J Virol"},{"issue":"7","key":"780_CR45","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.1128\/JVI.80.7.3617-3623.2006","volume":"80","author":"J Martinez-Picado","year":"2006","unstructured":"Martinez-Picado J, Prado JG, Fry EE, Pfafferott K, Leslie A, Chetty S, et al. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J Virol. 2006;80(7):3617\u201323.","journal-title":"J Virol"},{"issue":"4","key":"780_CR46","doi-asserted-by":"publisher","first-page":"e1000365","DOI":"10.1371\/journal.ppat.1000365","volume":"5","author":"RM Troyer","year":"2009","unstructured":"Troyer RM, McNevin J, Liu Y, Zhang SC, Krizan RW, Abraha A, et al. Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response. PLoS Pathog. 2009;5(4):e1000365.","journal-title":"PLoS Pathog"},{"issue":"12","key":"780_CR47","doi-asserted-by":"publisher","first-page":"E1480","DOI":"10.1073\/pnas.1421607112","volume":"112","author":"DT Claiborne","year":"2015","unstructured":"Claiborne DT, Prince JL, Scully E, Macharia G, Micci L, Lawson B, et al. Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4\u2009+\u2009T cells, and disease progression. Proc Natl Acad Sci U S A. 2015;112(12):E1480\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"780_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-021-00554-4","volume":"18","author":"O Farinre","year":"2021","unstructured":"Farinre O, Gounder K, Reddy T, Tongo M, Hare J, Chaplin B, et al. Subtype-specific differences in Gag-protease replication capacity of HIV-1 isolates from East and West Africa. Retrovirology. 2021;18(1):11.","journal-title":"Retrovirology"},{"key":"780_CR49","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1128\/JVI.00811-18","volume":"92","author":"DBA Ojwach","year":"2018","unstructured":"Ojwach DBA, MacMillan D, Reddy T, Novitsky V, Brumme ZL, Brockman MA, et al. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection. J Virol. 2018;92:19.","journal-title":"J Virol"},{"issue":"20","key":"780_CR50","doi-asserted-by":"publisher","first-page":"10820","DOI":"10.1128\/JVI.01084-10","volume":"84","author":"JK Wright","year":"2010","unstructured":"Wright JK, Brumme ZL, Carlson JM, Heckerman D, Kadie CM, Brumme CJ, et al. Gag-protease-mediated replication capacity in HIV-1 subtype C chronic infection: associations with HLA type and clinical parameters. J Virol. 2010;84(20):10820\u201331.","journal-title":"J Virol"},{"issue":"4","key":"780_CR51","first-page":"e03565","volume":"16","author":"O Baiyegunhi Omolara","year":"2025","unstructured":"Baiyegunhi Omolara O, Mthembu K, Reuschl A-K, Ojwach D, Farinre O, Maimela M, et al. HIV-1 gag-protease-driven replicative capacity influences T-cell metabolism, cytokine induction, and viral cell-to-cell spread. mBio. 2025;16(4):e03565-24.","journal-title":"mBio"},{"issue":"3","key":"780_CR52","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s11904-020-00495-1","volume":"17","author":"SJ Berendam","year":"2020","unstructured":"Berendam SJ, Nelson AN, Goswami R, Persaud D, Haigwood NL, Chahroudi A, et al. Pediatric HIV: the potential of immune therapeutics to achieve viral remission and functional cure. Curr HIV AIDS Rep. 2020;17(3):237\u201348.","journal-title":"Curr HIV AIDS Rep"},{"issue":"7","key":"780_CR53","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/s41590-024-01875-0","volume":"25","author":"Z Strongin","year":"2024","unstructured":"Strongin Z, Raymond Marchand L, Deleage C, Pampena MB, Cardenas MA, Beusch CM, et al. Distinct SIV-specific CD8\u2009+\u2009T cells in the lymph node exhibit simultaneous effector and stem-like profiles and are associated with limited SIV persistence. Nat Immunol. 2024;25(7):1245\u201356.","journal-title":"Nat Immunol"},{"issue":"1","key":"780_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-023-04975-z","volume":"6","author":"YY Wang","year":"2023","unstructured":"Wang YY, Zhen C, Hu W, Huang HH, Li YJ, Zhou MJ, et al. Elevated glutamate impedes anti-HIV-1 CD8\u2009+\u2009T cell responses in HIV-1-infected individuals on antiretroviral therapy. Commun Biol. 2023;6(1):696.","journal-title":"Commun Biol"},{"key":"780_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2020.101412","volume":"51","author":"AR Ward","year":"2021","unstructured":"Ward AR, Mota TM, Jones RB. Immunological approaches to HIV cure. Semin Immunol. 2021;51:101412.","journal-title":"Semin Immunol"},{"key":"780_CR56","doi-asserted-by":"crossref","unstructured":"Crater JM, Nixon DF, Furler O\u2019Brien RL. HIV-1 replication and latency are balanced by mTOR-driven cell metabolism. Front Cell Infect Microbiol. 2022;Volume 12\u20132022.","DOI":"10.3389\/fcimb.2022.1068436"},{"issue":"1","key":"780_CR57","doi-asserted-by":"publisher","first-page":"3922","DOI":"10.1038\/s41467-021-24077-w","volume":"12","author":"LB Giron","year":"2021","unstructured":"Giron LB, Palmer CS, Liu Q, Yin X, Papasavvas E, Sharaf R, et al. Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV. Nat Commun. 2021;12(1):3922.","journal-title":"Nat Commun"},{"issue":"1","key":"780_CR58","doi-asserted-by":"publisher","first-page":"5956","DOI":"10.1038\/s41467-022-33401-x","volume":"13","author":"F Real","year":"2022","unstructured":"Real F, Zhu A, Huang B, Belmellat A, Sennepin A, Vogl T, et al. S100A8-mediated metabolic adaptation controls HIV-1 persistence in macrophages in vivo. Nat Commun. 2022;13(1):5956.","journal-title":"Nat Commun"},{"key":"780_CR59","doi-asserted-by":"publisher","DOI":"10.20900\/immunometab20200005","author":"HE Taylor","year":"2020","unstructured":"Taylor HE, Palmer CS. CD4 T cell metabolism is a major contributor of HIV infectivity and reservoir persistence. Immunometabolism. 2020. https:\/\/doi.org\/10.20900\/immunometab20200005.","journal-title":"Immunometabolism"},{"key":"780_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/v17040486","author":"D Omara","year":"2025","unstructured":"Omara D, Natwijuka F, Kapaata A, Kato F, Kato L, Ndekezi C, et al. Subtype AD recombinant HIV-1 transmitted\/founder viruses are less sensitive to type I interferons than subtype D. Viruses. 2025. https:\/\/doi.org\/10.3390\/v17040486.","journal-title":"Viruses"},{"issue":"21","key":"780_CR61","doi-asserted-by":"publisher","first-page":"12623","DOI":"10.1128\/JVI.01705-14","volume":"88","author":"P Hraber","year":"2014","unstructured":"Hraber P, Korber BT, Lapedes AS, Bailer RT, Seaman MS, Gao H, et al. Impact of clade, geography, and age of the epidemic on HIV-1 neutralization by antibodies. J Virol. 2014;88(21):12623\u201343.","journal-title":"J Virol"},{"issue":"1","key":"780_CR62","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12977-021-00556-2","volume":"18","author":"R Mullick","year":"2021","unstructured":"Mullick R, Sutar J, Hingankar N, Deshpande S, Thakar M, Sahay S, et al. Neutralization diversity of HIV-1 Indian subtype C envelopes obtained from cross sectional and followed up individuals against broadly neutralizing monoclonal antibodies having distinct gp120 specificities. Retrovirology. 2021;18(1):12.","journal-title":"Retrovirology"},{"issue":"6","key":"780_CR63","doi-asserted-by":"publisher","first-page":"e0000825","DOI":"10.1128\/jvi.00008-25","volume":"99","author":"J Sutar","year":"2025","unstructured":"Sutar J, Jayal P, Mullick R, Chaudhary S, Kamble P, Bhowmick S, et al. Distinct region-specific neutralization profiles of contemporary HIV-1 clade C against best-in-class broadly neutralizing antibodies. J Virol. 2025;99(6):e0000825.","journal-title":"J Virol"},{"issue":"24","key":"780_CR64","doi-asserted-by":"publisher","first-page":"e0127022","DOI":"10.1128\/jvi.01270-22","volume":"96","author":"T Mandizvo","year":"2022","unstructured":"Mandizvo T, Gumede N, Ndlovu B, Ndlovu S, Mann JK, Chopera DR, et al. Subtle longitudinal alterations in Env sequence potentiate differences in sensitivity to broadly neutralizing antibodies following acute HIV-1 subtype C infection. J Virol. 2022;96(24):e0127022.","journal-title":"J Virol"},{"issue":"6","key":"780_CR65","doi-asserted-by":"publisher","first-page":"e1011469","DOI":"10.1371\/journal.ppat.1011469","volume":"19","author":"NN Mkhize","year":"2023","unstructured":"Mkhize NN, Yssel AEJ, Kaldine H, van Dorsten RT, Woodward Davis AS, Beaume N, et al. Neutralization profiles of HIV-1 viruses from the VRC01 antibody mediated prevention (AMP) trials. PLoS Pathog. 2023;19(6):e1011469.","journal-title":"PLoS Pathog"},{"key":"780_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines7030074","author":"K Stefic","year":"2019","unstructured":"Stefic K, Bouvin-Pley M, Braibant M, Barin F. Impact of HIV-1 diversity on its sensitivity to neutralization. Vaccines. 2019. https:\/\/doi.org\/10.3390\/vaccines7030074.","journal-title":"Vaccines"},{"issue":"2","key":"780_CR67","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s11481-011-9262-y","volume":"6","author":"JL Foster","year":"2011","unstructured":"Foster JL, Denial SJ, Temple BR, Garcia JV. Mechanisms of HIV-1 Nef function and intracellular signaling. J Neuroimmune Pharmacol. 2011;6(2):230\u201346.","journal-title":"J Neuroimmune Pharmacol"},{"issue":"7","key":"780_CR68","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1093\/embo-reports\/kve141","volume":"2","author":"M Geyer","year":"2001","unstructured":"Geyer M, Fackler OT, Peterlin BM. Structure\u2013function relationships in HIV-1 Nef. EMBO Rep. 2001;2(7):580\u20135.","journal-title":"EMBO Rep"},{"issue":"3","key":"780_CR69","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1089\/aid.2008.0132","volume":"25","author":"G Turk","year":"2009","unstructured":"Turk G, Gundlach S, Carobene M, Schindler M, Salomon H, Benaroch P. Single Nef proteins from HIV type 1 subtypes C and F fail to upregulate invariant chain cell surface expression but are active for other functions. AIDS Res Hum Retroviruses. 2009;25(3):285\u201396.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"3","key":"780_CR70","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1006\/bbrc.2001.5026","volume":"284","author":"K Yoon","year":"2001","unstructured":"Yoon K, Jeong JG, Yoon H, Lee JS, Kim S. Differential effects of primary human immunodeficiency virus type 1 nef sequences on downregulation of CD4 and MHC class I. Biochem Biophys Res Commun. 2001;284(3):638\u201342.","journal-title":"Biochem Biophys Res Commun"},{"key":"780_CR71","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/1742-4690-10-100","volume":"10","author":"JK Mann","year":"2013","unstructured":"Mann JK, Byakwaga H, Kuang XT, Le AQ, Brumme CJ, Mwimanzi P, et al. Ability of HIV-1 Nef to downregulate CD4 and HLA class I differs among viral subtypes. Retrovirology. 2013;10:100.","journal-title":"Retrovirology"},{"issue":"5","key":"780_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanmic.2024.101018","volume":"6","author":"MJ Mumby","year":"2025","unstructured":"Mumby MJ, Prodger JL, Hackman J, Saraf S, Zhu X, Ferreira RC, et al. Association between HIV-1 Nef-mediated MHC-I downregulation and the maintenance of the replication-competent latent viral reservoir in individuals with virally suppressed HIV-1 in Uganda: an exploratory cohort study. Lancet Microbe. 2025;6(5):101018.","journal-title":"Lancet Microbe"},{"issue":"36","key":"780_CR73","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adx7485","volume":"11","author":"S Dehn","year":"2025","unstructured":"Dehn S, Burkhard R, Leyens J, Kaiser T, Brandimarte S, Heiligensetzer D, et al. HIV-1 manipulates CD96 on CD4(+) T cells to subvert antiviral immunity. Sci Adv. 2025;11(36):eadx7485.","journal-title":"Sci Adv"},{"issue":"9","key":"780_CR74","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.4049\/jimmunol.1800372","volume":"201","author":"I del R\u00edo-I\u00f1iguez","year":"2018","unstructured":"del R\u00edo-I\u00f1iguez I, V\u00e1zquez-Ch\u00e1vez E, Cuche C, Di Bartolo V, Bouchet J, Alcover A. HIV-1 Nef hijacks Lck and Rac1 endosomal traffic to dually modulate signaling-mediated and actin cytoskeleton\u2013mediated T cell functions. J Immunol. 2018;201(9):2624\u201340.","journal-title":"J Immunol"},{"issue":"53","key":"780_CR75","doi-asserted-by":"publisher","first-page":"44714","DOI":"10.1074\/jbc.M112.397158","volume":"287","author":"M Bachu","year":"2012","unstructured":"Bachu M, Yalla S, Asokan M, Verma A, Neogi U, Sharma S, et al. Multiple NF-kappaB sites in HIV-1 subtype C long terminal repeat confer superior magnitude of transcription and thereby the enhanced viral predominance. J Biol Chem. 2012;287(53):44714\u201335.","journal-title":"J Biol Chem"},{"issue":"11","key":"780_CR76","doi-asserted-by":"publisher","first-page":"8657","DOI":"10.1128\/jvi.71.11.8657-8665.1997","volume":"71","author":"MA Montano","year":"1997","unstructured":"Montano MA, Novitsky VA, Blackard JT, Cho NL, Katzenstein DA, Essex M. Divergent transcriptional regulation among expanding human immunodeficiency virus type 1 subtypes. J Virol. 1997;71(11):8657\u201365.","journal-title":"J Virol"},{"issue":"2","key":"780_CR77","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1128\/JVI.73.2.1331-1340.1999","volume":"73","author":"K Verhoef","year":"1999","unstructured":"Verhoef K, Sanders RW, Fontaine V, Kitajima S, Berkhout B. Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-kappaB enhancer element into a GABP binding site. J Virol. 1999;73(2):1331\u201340.","journal-title":"J Virol"},{"issue":"7","key":"780_CR78","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1128\/JVI.78.7.3675-3683.2004","volume":"78","author":"T van Opijnen","year":"2004","unstructured":"van Opijnen T, Jeeninga RE, Boerlijst MC, Pollakis GP, Zetterberg V, Salminen M, et al. Human immunodeficiency virus type 1 subtypes have a distinct long terminal repeat that determines the replication rate in a host-cell-specific manner. J Virol. 2004;78(7):3675\u201383.","journal-title":"J Virol"},{"issue":"10","key":"780_CR79","doi-asserted-by":"publisher","first-page":"5732","DOI":"10.1128\/JVI.03297-12","volume":"87","author":"R Rossenkhan","year":"2013","unstructured":"Rossenkhan R, MacLeod IJ, Sebunya TK, Castro-Nallar E, McLane MF, Musonda R, et al. tat Exon 1 exhibits functional diversity during HIV-1 subtype C primary infection. J Virol. 2013;87(10):5732\u201345.","journal-title":"J Virol"},{"issue":"6","key":"780_CR80","doi-asserted-by":"publisher","first-page":"e1011194","DOI":"10.1371\/journal.ppat.1011194","volume":"19","author":"P Madlala","year":"2023","unstructured":"Madlala P, Mkhize Z, Naicker S, Khathi SP, Maikoo S, Gopee K, et al. Genetic variation of the HIV-1 subtype C transmitted\/founder viruses long terminal repeat elements and the impact on transcription activation potential and clinical disease outcomes. PLoS Pathog. 2023;19(6):e1011194.","journal-title":"PLoS Pathog"},{"key":"780_CR81","doi-asserted-by":"crossref","unstructured":"Berger EA, Murphy PM, Farber JM. CHEMOKINE RECEPTORS AS HIV-1 CORECEPTORS: Roles in Viral Entry, Tropism, and Disease. Annual Review of Immunology. 1999;17(Volume 17, 1999):657\u2013700.","DOI":"10.1146\/annurev.immunol.17.1.657"},{"issue":"4","key":"780_CR82","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1084\/jem.185.4.621","volume":"185","author":"RI Connor","year":"1997","unstructured":"Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR. Change in coreceptor use correlates with disease progression in HIV-1\u2013infected individuals. J Exp Med. 1997;185(4):621\u20138.","journal-title":"J Exp Med"},{"issue":"1","key":"780_CR83","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1089\/088922204322749567","volume":"20","author":"JP Moore","year":"2004","unstructured":"Moore JP, Kitchen SG, Pugach P, Zack JA. The CCR5 and CXCR4 coreceptors\u2013central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses. 2004;20(1):111\u201326.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"2","key":"780_CR84","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1006\/viro.1997.8980","volume":"241","author":"C Tscherning","year":"1998","unstructured":"Tscherning C, Alaeus A, Fredriksson R, Bj\u00f6rndal \u00c5, Deng H, Littman DR, et al. Differences in Chemokine Coreceptor Usage between Genetic Subtypes of HIV-1. Virology. 1998;241(2):181\u20138.","journal-title":"Virology"},{"issue":"7","key":"780_CR85","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1089\/aid.2006.22.703","volume":"22","author":"K Felsovalyi","year":"2006","unstructured":"Felsovalyi K, Nadas A, Zolla-Pazner S, Cardozo T. Distinct sequence patterns characterize the V3 region of HIV type 1 gp120 from subtypes A and C. AIDS Res Hum Retroviruses. 2006;22(7):703\u20138.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"1","key":"780_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/1758-2652-15-2","volume":"15","author":"Q Ataher","year":"2012","unstructured":"Ataher Q, Portsmouth S, Napolitano LA, Eng S, Greenacre A, Kambugu A, et al. The epidemiology and clinical correlates of HIV-1 co-receptor tropism in non-subtype B infections from India, Uganda and South Africa. J Int AIDS Soc. 2012;15(1):2.","journal-title":"J Int AIDS Soc"},{"issue":"15","key":"780_CR87","doi-asserted-by":"publisher","first-page":"7885","DOI":"10.1128\/JVI.00218-07","volume":"81","author":"W Huang","year":"2007","unstructured":"Huang W, Eshleman SH, Toma J, Fransen S, Stawiski E, Paxinos EE, et al. Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations. J Virol. 2007;81(15):7885\u201393.","journal-title":"J Virol"},{"key":"780_CR88","doi-asserted-by":"crossref","unstructured":"Bednar MM, Hauser BM, Zhou S, Jacobson JM, Eron JJ, Jr. FI, et al. Diversity and tropism of HIV-1 rebound virus populations in plasma level after treatment discontinuation. J Infect Dis. 2016;214(3):403\u20137.","DOI":"10.1093\/infdis\/jiw172"},{"issue":"1","key":"780_CR89","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1128\/JVI.06082-11","volume":"86","author":"M Binka","year":"2012","unstructured":"Binka M, Ooms M, Steward M, Simon V. The activity spectrum of Vif from multiple HIV-1 subtypes against APOBEC3G, APOBEC3F, and APOBEC3H. J Virol. 2012;86(1):49\u201359.","journal-title":"J Virol"},{"issue":"13","key":"780_CR90","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1097\/QAD.0b013e328277f16b","volume":"21","author":"AS Bano","year":"2007","unstructured":"Bano AS, Gupta N, Sood V, Banerjea AC. Vpr from HIV-1 subtypes B and C exhibit significant differences in their ability to transactivate LTR-mediated gene expression and also in their ability to promote apoptotic DNA ladder formation. AIDS. 2007;21(13):1832\u20134.","journal-title":"AIDS"},{"key":"780_CR91","doi-asserted-by":"crossref","unstructured":"Langer S, Hammer C, Hopfensperger K, Klein L, Hotter D, De Jesus PD et al. HIV-1 Vpu is a potent transcriptional suppressor of NF-kappaB-elicited antiviral immune responses. Elife. 2019;8.","DOI":"10.7554\/eLife.41930"},{"key":"780_CR92","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00293-20","author":"G Umviligihozo","year":"2020","unstructured":"Umviligihozo G, Cobarrubias KD, Chandrarathna S, Jin SW, Reddy N, Byakwaga H, et al. Differential Vpu-mediated CD4 and tetherin downregulation functions among major HIV-1 group M subtypes. J Virol. 2020. https:\/\/doi.org\/10.1128\/JVI.00293-20.","journal-title":"J Virol"},{"issue":"1","key":"780_CR93","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1146\/annurev-virology-111821-100816","volume":"10","author":"M Volcic","year":"2023","unstructured":"Volcic M, Wiesmuller L, Kirchhoff F. Small but highly versatile: the viral accessory protein Vpu. Annu Rev Virol. 2023;10(1):243\u201359.","journal-title":"Annu Rev Virol"},{"issue":"6193","key":"780_CR94","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1126\/science.1254194","volume":"345","author":"F Maldarelli","year":"2014","unstructured":"Maldarelli F, Wu X, Su L, Simonetti FR, Shao W, Hill S, et al. HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells. Science. 2014;345(6193):179\u201383.","journal-title":"Science"},{"issue":"6196","key":"780_CR95","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1126\/science.1256304","volume":"345","author":"TA Wagner","year":"2014","unstructured":"Wagner TA, McLaughlin S, Garg K, Cheung CY, Larsen BB, Styrchak S, et al. HIV latency. Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection. Science. 2014;345(6196):570\u20133.","journal-title":"Science"},{"issue":"1","key":"780_CR96","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1038\/s41467-019-10884-9","volume":"10","author":"N Bachmann","year":"2019","unstructured":"Bachmann N, von Siebenthal C, Vongrad V, Turk T, Neumann K, Beerenwinkel N, et al. Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART. Nat Commun. 2019;10(1):3193.","journal-title":"Nat Commun"},{"issue":"8","key":"780_CR97","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1093\/cid\/cix478","volume":"65","author":"JL Prodger","year":"2017","unstructured":"Prodger JL, Lai J, Reynolds SJ, Keruly JC, Moore RD, Kasule J, et al. Reduced Frequency of Cells Latently Infected With Replication-Competent Human Immunodeficiency Virus-1 in Virally Suppressed Individuals Living in Rakai, Uganda. Clin Infect Dis. 2017;65(8):1308\u201315.","journal-title":"Clin Infect Dis"},{"key":"780_CR98","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01832-18","author":"FH Omondi","year":"2019","unstructured":"Omondi FH, Chandrarathna S, Mujib S, Brumme CJ, Jin SW, Sudderuddin H, et al. HIV subtype and Nef-mediated immune evasion function correlate with viral reservoir size in early-treated individuals. J Virol. 2019. https:\/\/doi.org\/10.1128\/JVI.01832-18.","journal-title":"J Virol"},{"issue":"1","key":"780_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12977-022-00587-3","volume":"19","author":"S Joussef-Pina","year":"2022","unstructured":"Joussef-Pina S, Nankya I, Nalukwago S, Baseke J, Rwambuya S, Winner D, et al. Reduced and highly diverse peripheral HIV-1 reservoir in virally suppressed patients infected with non-B HIV-1 strains in Uganda. Retrovirology. 2022;19(1):1.","journal-title":"Retrovirology"}],"container-title":["Current HIV\/AIDS Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-026-00780-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11904-026-00780-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11904-026-00780-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T05:07:51Z","timestamp":1774588071000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11904-026-00780-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":99,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["780"],"URL":"https:\/\/doi.org\/10.1007\/s11904-026-00780-5","relation":{},"ISSN":["1548-3576"],"issn-type":[{"value":"1548-3576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"13 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}